You are here

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Arcadia, California, 91007-3462 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Generalized Anxiety Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adult male and female subjects with primary DSM-IV diagnosis of GAD, as confirmed by
the MINI structured interview.

- Historical failure to respond optimally to a GAD treatment

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Current primary DSM-IV (Diagnostic and Statistical Manual of Mental Disorders 4th
edition) diagnosis of major depressive disorder with or without seasonal pattern,
dysthmic disorder, depressive disorder NOS (not otherwise specified), social phobia,
panic disorder with or without agoraphobia, post traumatic stress disorder,
dissociative disorder, borderline personality disorder, obsessive-compulsive disorder,
antisocial personality disorder, as defined in the DSM-IV TR (Diagnostic and
Statistical Manual of Mental Disorders 4th edition, Text Revision).

- Past and/or current DSM-IV diagnosis of schizophrenia, schizoaffective disorder, other
psychotic disorders, bipolar disorders (I or II), factitious disorder or cognitive
disorder (including delirium, dementia, and amnestic disorder).

NCT00413010
Pfizer
Completed
Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Generalized Anxiety Disorder
NCT02310568
All Genders
18+
Years
Multiple Sites
Generalized Anxiety Disorder
NCT00658372
All Genders
18+
Years
Multiple Sites
Generalized Anxiety Disorder
NCT00624780
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now